These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31702806)

  • 41. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
    Long P; Sun F; Ma Y; Huang Y
    Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
    Nazari A; Khorramdelazad H; Hassanshahi G
    Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Significance of chemokine receptor CXCR3 expression in breast cancer].
    Li L; Chen J; Lu ZH; Yu SN; Luo YF; Zhao WG; Ma YH; Jia CW
    Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):85-8. PubMed ID: 21426802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long non-coding RNA00544 serves as a potential novel predictive and prognostic marker for HR+ HER2- subtype breast cancer.
    Liu L; Chi Y; Chen J; Xue J; Deng L; Huang N; Shao J; Wu J
    Sci Rep; 2017 Sep; 7(1):12382. PubMed ID: 28959047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CXCR4 Expression is Associated with Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.
    Goto M; Yoshida T; Yamamoto Y; Furukita Y; Inoue S; Fujiwara S; Kawakita N; Nishino T; Minato T; Yuasa Y; Yamai H; Takechi H; Seike J; Bando Y; Tangoku A
    Ann Surg Oncol; 2017 Mar; 24(3):832-840. PubMed ID: 26577115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment.
    Chen B; Zhang S; Li Q; Wu S; He H; Huang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of FOXM1 and CXCR4 as key genes in breast cancer prevention and prognosis after intermittent energy restriction through bioinformatics and functional analyses.
    Li L; Chen L; Yu L; Zhang J; Chen L
    Adipocyte; 2022 Dec; 11(1):301-314. PubMed ID: 35481418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer.
    D'Alterio C; Consales C; Polimeno M; Franco R; Cindolo L; Portella L; Cioffi M; Calemma R; Marra L; Claudio L; Perdonà S; Pignata S; Facchini G; Cartenì G; Longo N; Pucci L; Ottaiano A; Costantini S; Castello G; Scala S
    Curr Cancer Drug Targets; 2010 Nov; 10(7):772-81. PubMed ID: 20578990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients.
    Sand LG; Scotlandi K; Berghuis D; Snaar-Jagalska BE; Picci P; Schmidt T; Szuhai K; Hogendoorn PC
    Eur J Cancer; 2015 Nov; 51(17):2624-33. PubMed ID: 26428435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic and immunological value of
    Wang J; Liu Y; Zhang S
    Aging (Albany NY); 2021 Jul; 13(13):16904-16921. PubMed ID: 34228637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma.
    McConnell AT; Ellis R; Pathy B; Plummer R; Lovat PE; O'Boyle G
    Br J Dermatol; 2016 Dec; 175(6):1210-1220. PubMed ID: 27167239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of the chemokine receptors CXCR3, CXCR4 and CCR7 in the intramuscular recruitment of plasmacytoid dendritic cells in dermatomyositis.
    Lv J; Li L; Li W; Ji K; Hou Y; Yan C; Dai T
    J Neuroimmunol; 2018 Jun; 319():142-148. PubMed ID: 29366593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases.
    Chen MN; Zeng D; Zheng ZQ; Li Z; Wu JL; Jin JY; Wang HJ; Huang CZ; Lin HY
    J Vis Exp; 2019 May; (147):. PubMed ID: 31157790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer.
    Iwakiri S; Mino N; Takahashi T; Sonobe M; Nagai S; Okubo K; Wada H; Date H; Miyahara R
    Cancer; 2009 Jun; 115(11):2580-93. PubMed ID: 19309748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prognostic value of JUNB-positive CTCs in metastatic breast cancer: from bioinformatics to phenotypic characterization.
    Kallergi G; Tsintari V; Sfakianakis S; Bei E; Lagoudaki E; Koutsopoulos A; Zacharopoulou N; Alkahtani S; Alarifi S; Stournaras C; Zervakis M; Georgoulias V
    Breast Cancer Res; 2019 Aug; 21(1):86. PubMed ID: 31370904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High level of CXCR4 in triple-negative breast cancer specimens associated with a poor clinical outcome.
    Yu S; Wang X; Liu G; Zhu X; Chen Y
    Acta Med Okayama; 2013; 67(6):369-75. PubMed ID: 24356721
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic and diagnostic roles of prolyl 4-hydroxylase subunit α members in breast cancer.
    Li M; Wang Q; Zheng Q; Wu L; Zhao B; Wu Y
    Biomark Med; 2021 Sep; 15(13):1085-1095. PubMed ID: 34387118
    [No Abstract]   [Full Text] [Related]  

  • 60. Coregulation of CXC chemokine receptor and CD4 expression on T lymphocytes during allogeneic activation.
    Ebert LM; McColl SR
    J Immunol; 2001 Apr; 166(8):4870-8. PubMed ID: 11290763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.